Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Ramky Infra bags ₹3,000 cr Pharma Park project
Ramky Infrastructure Ltd (RIL) has said that it bagged a ₹3,000-crore project to develop a ‘high-tech Pharmaceutical Park' at the Dighi Port Industrial Area in Raigad district of Maharashtra. The project will establish a large-scale…
aTyr Pharma (NASDAQ:ATYR) Upgraded at Wall Street Zen
aTyr Pharma (NASDAQ:ATYR - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a report released on Sunday. ATYR has been the topic of several other reports. Weiss Ratings…
Ally Bridge Group NY LLC Acquires Shares of 51,080 Ascendis Pharma A/S $ASND
Ally Bridge Group NY LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought…
New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST
Featured Companies: FLOKI (CRYPTO:FLOKI), KLED.AI, Sagtech Global (NASDAQ:SAGT), Medicus Pharma (NASDAQ:MDCX), and YY Group (NASDAQ:YYGH) New to The Street, the nationally recognized business television platform showcasing innovative public and…
The most powerful Oscar nominee you didn't see
Hiding in plain sight that night, among the patrons scattered throughout the museum, was photographer and activist Nan Goldin, along with several members of her advocacy group, P.A.I.N. (Prescription Addiction Intervention Now). Goldin and P.A.I.N.
Growth Stocks To Follow Now - March 14th
3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener…
OmniAb (OABI) Q4 2025 Earnings Call Transcript
President and Chief Executive Officer — Matthew W. Foehr Chief Financial Officer — Kurt A. Gustafson Active partners -- Reached 107 by year-end, reflecting business growth and broadening geographic presence. Active programs --…
Bandu's Blockbusters For March 15, 2026
On April 1, four years ago, piqued by the incessant jokes in the village at his expense, Bandu Barve decided he'd had enough. It was time for him to turn ‘smart'. His dead granny's voice rang in his ears — “Read the papers…
The Modi myth and the false binary of Hindutva vs economic development
A few days after fresh instances of censorship (an actor's claim of being disinvited from a university event for his anti-establishment views and the cancellation of a scheduled discussion on political prisoners by a prominent Mumbai cultural…
Mineralys Therapeutics (NASDAQ:MLYS) Upgraded to Hold at Wall Street Zen
Mineralys Therapeutics (NASDAQ:MLYS - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a note issued to investors on Sunday. There's a Lot to Love About Mineralys' Valentine's Day…
Gavin Newsom: Trump talks about the drug crisis, California is acting
Almost every family in America, in one way or another, has suffered from the drug overdose epidemic that takes tens of thousands of lives each year. This epidemic has run rampant for decades, touching every community, every socioeconomic class, and…
Mineralys Therapeutics, Inc. $MLYS Shares Sold by 22NW LP
22NW LP reduced its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 36.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 358,325 shares of the company's…
Alpine Fox Capital LLC Takes Position in Novo Nordisk A/S $NVO
Alpine Fox Capital LLC bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 61,000 shares of…
Aristotle Capital Management LLC Reduces Stock Position in Roche Holding AG $RHHBY
Aristotle Capital Management LLC cut its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 1.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned…
Fortrea Holdings Inc. (NASDAQ:FTRE) Given Average Rating of 'Hold' by Brokerages
Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) has earned an average rating of 'Hold' from the eleven analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell…
Receive a Daily briefing on Pharma Industry News
Get Started